Earnings calls

Laxmi Organic concall ledger

Every earnings call for LXCHEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

LXCHEM · 5 transcripts · Chemicals · latest Q3 FY26

Q3 FY26Published 30 Jan 2026Call held 30 Jan 2026

LXCHEM Q3 FY26 Earnings Call Transcript & Analysis

EBITDA₹50 cr−33% YoYPAT₹25 cr−15% YoY

EBITDA ₹50 cr (−33% YoY); PAT ₹25 cr (−15% YoY). PAT for Q3 FY26 stood at INR 25 crores, down from INR 29.3 crores in the previous year.

Read full transcript & analysis

Q2 FY26Published 30 Oct 2025Call held 30 Oct 2025

LXCHEM Q2 FY26 Earnings Call Transcript & Analysis

Total Revenue₹807.63 cr−9% YoYEBITDA₹37 cr−50% YoYEBITDA Margin5.3%PAT₹11 cr−61% YoY

Total Revenue ₹808 cr (−9% YoY); EBITDA ₹37 cr (−50% YoY); EBITDA Margin 5.3%. Total revenue declined by 9% YoY to approximately INR 807.6 crores in Q2 FY26.

Read full transcript & analysis

Q1 FY26Published 29 Jul 2025Call held 29 Jul 2025

LXCHEM Q1 FY26 Earnings Call Transcript & Analysis

PAT₹21.4 cr−38% YoYPAT Margin3.1%

PAT ₹21 cr (−38% YoY); PAT Margin 3.1%. Overall revenue de-grew by nearly 4% in Q1 FY26, despite an 8% volume growth.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

LXCHEM Q4 FY25 Earnings Call Transcript & Analysis

Adjusted EBITDA590 millionEBITDA Margin9.4%PAT Margin3.8%Gross Margin34.6%

Adjusted EBITDA (Q4 FY25) 590 million; EBITDA Margin (FY25) 9.4%; PAT Margin (FY25) 3.8%. Full year FY25 volume growth was 11% overall, with specialty chemicals growing 7% and essentials (acetyls) at 12.5%.

Read full transcript & analysis

Q3 FY25Published 23 Jan 2025Call held 23 Jan 2025

LXCHEM Q3 FY25 Earnings Call Transcript & Analysis

EBITDA₹75 cr+241% YoYGross Margin33.1%

EBITDA ₹75 cr (+241% YoY); Gross Margin 33.1%. Sales grew 13% year-on-year in Q3 FY25.

Read full transcript & analysis